AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2015
Oct 1, 2015
31949_dirs_2015-10-01_bb952b91-25e0-4afc-88eb-006d20388c8f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-01
Reporting Person: Langloss Timothy J. (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 32308 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants | $3.59 | 2016-05-08 | Ordinary Shares (3340) | Direct | |
| Warrants | $3.59 | 2017-07-31 | Ordinary Shares (2708) | Direct | |
| Warrants | $3.59 | 2018-07-21 | Ordinary Shares (1620) | Direct |
Footnotes
F1: Currently exercisable as of the date hereof.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Earnings Release
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Board/Management Information
2026
Apr 24
Board/Management Information
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3